Literature DB >> 15006500

NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia.

Joseph T Coyle1, Guochuan Tsai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006500     DOI: 10.1016/S0074-7742(04)59019-0

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  47 in total

Review 1.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

Review 2.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 3.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

4.  Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI.

Authors:  S Sekar; E Jonckers; M Verhoye; R Willems; J Veraart; J Van Audekerke; J Couto; M Giugliano; K Wuyts; S Dedeurwaerdere; J Sijbers; C Mackie; L Ver Donck; T Steckler; A Van der Linden
Journal:  Psychopharmacology (Berl)       Date:  2013-01-25       Impact factor: 4.530

Review 5.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.

Authors:  Miranda L Fisher; Anu Loukola; Jaakko Kaprio; Jill R Turner
Journal:  Int Rev Neurobiol       Date:  2015-09-16       Impact factor: 3.230

6.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

7.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

Review 8.  Imaging genetics of structural brain connectivity and neural integrity markers.

Authors:  Stefano Marenco; Eugenia Radulescu
Journal:  Neuroimage       Date:  2009-11-22       Impact factor: 6.556

9.  Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats.

Authors:  Tracie A Paine; William A Carlezon
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.250

10.  Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.

Authors:  Abraham A Palmer; Alan S Brown; Debbra Keegan; Lara DeSanti Siska; Ezra Susser; John Rotrosen; Pamela D Butler
Journal:  Brain Res       Date:  2008-07-30       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.